ES2192832T3 - Uso de compuestos macrolidos para tratar glaucoma. - Google Patents
Uso de compuestos macrolidos para tratar glaucoma.Info
- Publication number
- ES2192832T3 ES2192832T3 ES99905206T ES99905206T ES2192832T3 ES 2192832 T3 ES2192832 T3 ES 2192832T3 ES 99905206 T ES99905206 T ES 99905206T ES 99905206 T ES99905206 T ES 99905206T ES 2192832 T3 ES2192832 T3 ES 2192832T3
- Authority
- ES
- Spain
- Prior art keywords
- compounds
- treat glaucoma
- macrolid
- macrolid compounds
- glaucoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4433—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Esta invención proporciona un nuevo uso de los compuestos de macrólido para prevenir o tratar glaucoma. Adicionalmente, esta invención proporciona un agente profiláctico o terapéutico para el glaucoma, que comprende los compuestos de macrólido.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPP1955A AUPP195598A0 (en) | 1998-02-23 | 1998-02-23 | New use |
AUPP2992A AUPP299298A0 (en) | 1998-04-16 | 1998-04-16 | New use |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2192832T3 true ES2192832T3 (es) | 2003-10-16 |
Family
ID=25645716
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES99905206T Expired - Lifetime ES2192832T3 (es) | 1998-02-23 | 1999-02-17 | Uso de compuestos macrolidos para tratar glaucoma. |
Country Status (9)
Country | Link |
---|---|
US (1) | US6384073B1 (es) |
EP (1) | EP1056454B1 (es) |
JP (1) | JP2002503692A (es) |
AT (1) | ATE238792T1 (es) |
DE (1) | DE69907418T2 (es) |
DK (1) | DK1056454T3 (es) |
ES (1) | ES2192832T3 (es) |
PT (1) | PT1056454E (es) |
WO (1) | WO1999042104A1 (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7338976B1 (en) * | 1998-08-14 | 2008-03-04 | Gpi Nil Holdings, Inc. | Heterocyclic esters or amides for vision and memory disorders |
US7265150B1 (en) * | 1998-08-14 | 2007-09-04 | Gpi Nil Holdings Inc. | Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds for vision and memory disorders |
US6376517B1 (en) * | 1998-08-14 | 2002-04-23 | Gpi Nil Holdings, Inc. | Pipecolic acid derivatives for vision and memory disorders |
US20070032853A1 (en) | 2002-03-27 | 2007-02-08 | Hossainy Syed F | 40-O-(2-hydroxy)ethyl-rapamycin coated stent |
DE60029985T2 (de) * | 1999-11-12 | 2007-02-01 | Alcon Inc. | Verwendung von neurophilin liganden zur behandlung von augenerkrankungen |
GB0012383D0 (en) * | 2000-05-22 | 2000-07-12 | Novartis Ag | Organic compounds |
WO2003061519A2 (en) * | 2002-01-18 | 2003-07-31 | Massachusetts Eye And Ear Infirmary | Methods and compositions for preserving the viability of photoreceptor cells |
US7354574B2 (en) | 2002-11-07 | 2008-04-08 | Advanced Ocular Systems Limited | Treatment of ocular disease |
US20050118344A1 (en) | 2003-12-01 | 2005-06-02 | Pacetti Stephen D. | Temperature controlled crimping |
US7083802B2 (en) | 2003-07-31 | 2006-08-01 | Advanced Ocular Systems Limited | Treatment of ocular disease |
US7087237B2 (en) | 2003-09-19 | 2006-08-08 | Advanced Ocular Systems Limited | Ocular solutions |
US7083803B2 (en) | 2003-09-19 | 2006-08-01 | Advanced Ocular Systems Limited | Ocular solutions |
TW200517114A (en) | 2003-10-15 | 2005-06-01 | Combinatorx Inc | Methods and reagents for the treatment of immunoinflammatory disorders |
CA2615990A1 (en) | 2005-07-18 | 2007-01-25 | Minu, L.L.C. | Enhanced ocular neuroprotection/neurostimulation |
US7592330B2 (en) * | 2005-08-08 | 2009-09-22 | Massachusetts Eye And Ear Infirmary | Methods and compositions for preserving the viability of photoreceptor cells |
US8067433B2 (en) | 2005-11-09 | 2011-11-29 | Zalicus Inc. | Methods, compositions, and kits for the treatment of ophthalmic disorders |
CA2664697A1 (en) | 2006-09-28 | 2008-04-10 | Follica, Inc. | Methods, kits, and compositions for generating new hair follicles and growing hair |
KR20090094090A (ko) * | 2006-12-28 | 2009-09-03 | 리머릭 바이오파르마 인코오포레이티드 | 치료를 위한 방법 및 조성물 |
EP2124898B1 (en) * | 2007-01-10 | 2013-08-14 | Board of Regents, The University of Texas System | Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery |
EP2182957A4 (en) * | 2007-07-31 | 2012-07-18 | Limerick Biopharma Inc | PHOSPHORYLATED PYRONANALOGES AND CORRESPONDING METHODS |
US20100092479A1 (en) * | 2008-08-18 | 2010-04-15 | Combinatorx (Singapore) Pte. Ltd. | Compositions and methods for treatment of viral diseases |
US20110130711A1 (en) * | 2009-11-19 | 2011-06-02 | Follica, Inc. | Hair growth treatment |
WO2012118863A1 (en) * | 2011-02-28 | 2012-09-07 | The Schepens Eye Research Institute, Inc. | Therapies that target autoimmunity for treating glaucoma and optic neuropathy |
CA2935167C (en) | 2014-01-16 | 2022-02-22 | Musc Foundation For Research Development | Targeted nanocarriers for the administration of immunosuppressive agents |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4894366A (en) * | 1984-12-03 | 1990-01-16 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
IE65341B1 (en) * | 1990-11-08 | 1995-10-18 | Fujisawa Pharmaceutical Co | Suspensions containing tricyclic compounds |
CA2102241C (en) * | 1991-04-26 | 2003-12-30 | Manabu Mochizuki | Use of macrolide compounds for eye diseases |
IL102414A (en) * | 1991-07-25 | 1996-08-04 | Univ Louisville Res Found | Medicinal preparations for the treatment of ocular inflammation, containing rapamycin |
US5922773A (en) * | 1992-12-04 | 1999-07-13 | The Children's Medical Center Corp. | Glaucoma treatment |
US5912224A (en) * | 1996-02-22 | 1999-06-15 | The General Hospital Corporation | Methods and compositions for enhancing cellular response to TGF-β ligands |
US5994388A (en) * | 1997-03-18 | 1999-11-30 | The Children's Medical Center Corporation | Cytochalasin and isoindolinone derivatives as inhibitors of angiogenesis |
-
1999
- 1999-02-17 ES ES99905206T patent/ES2192832T3/es not_active Expired - Lifetime
- 1999-02-17 DK DK99905206T patent/DK1056454T3/da active
- 1999-02-17 JP JP2000532120A patent/JP2002503692A/ja active Pending
- 1999-02-17 PT PT99905206T patent/PT1056454E/pt unknown
- 1999-02-17 AT AT99905206T patent/ATE238792T1/de not_active IP Right Cessation
- 1999-02-17 EP EP99905206A patent/EP1056454B1/en not_active Expired - Lifetime
- 1999-02-17 DE DE69907418T patent/DE69907418T2/de not_active Expired - Fee Related
- 1999-02-17 WO PCT/JP1999/000681 patent/WO1999042104A1/en active IP Right Grant
- 1999-02-17 US US09/622,035 patent/US6384073B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1056454A1 (en) | 2000-12-06 |
PT1056454E (pt) | 2003-08-29 |
DE69907418T2 (de) | 2003-11-13 |
WO1999042104A1 (en) | 1999-08-26 |
ATE238792T1 (de) | 2003-05-15 |
DK1056454T3 (da) | 2003-08-18 |
US6384073B1 (en) | 2002-05-07 |
EP1056454B1 (en) | 2003-05-02 |
DE69907418D1 (de) | 2003-06-05 |
JP2002503692A (ja) | 2002-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2192832T3 (es) | Uso de compuestos macrolidos para tratar glaucoma. | |
ID21526A (id) | 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus | |
BR9911482A (pt) | Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto | |
DK0915898T3 (da) | Krystalform I af clarithromycin | |
ID18883A (id) | Pesaing 5-ht 1f | |
BR9408323A (pt) | Derivados de rapamicina | |
BRPI0207961A8 (pt) | Uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos. | |
ID29393A (id) | Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah | |
ATE468889T1 (de) | Kosmetische zusammensetzung zur behandlung von alternder und/oder gestresster haut | |
DE59409312D1 (de) | Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten | |
ES2080297T3 (es) | Derivados 17-g(b)-sustituido-4-aza-5g(a)-androstan-3-ona y procedimiento de preparacion de estos. | |
DE69940951D1 (de) | Nd wachstumshemmende mittel | |
BR0318278A (pt) | compostos de éter aminocicloexìlico e usos dos mesmo | |
BR0015392A (pt) | Lipoxina a4 e seus análogos para o tratamento de olho ressecado | |
BR0109211A (pt) | Compostos com atividade 5-ht1a úteis para o tratamento de distúrbios da retina externa | |
BR0011225A (pt) | Agente para tratar de olhos secos, seu método e uso | |
BRPI0017528B8 (pt) | uso de uma composição contendo sal de cetotifeno | |
BR9914128A (pt) | Composições antibióticas para tratamento do olho, ouvido e nariz | |
PT932613E (pt) | Expressao de bloqueio de factoes de virulencia em s. aureus | |
BR0016680B1 (pt) | Composição amaciante de tecidos, método para tratar tecido, uso de um derivado oleoso de açúcar, e, derivado oleoso de açúcar. | |
AU2001289714A1 (en) | Benzofuran derivatives and their use as antibacterial agents | |
BR9908796A (pt) | Uso de compostos de macrolìdeo, método de tratamento e prevenção de ards, composição farmacêutica e composto macrolìdeo | |
RU94045256A (ru) | Применение бензо[g]хинолинов | |
ES2153584T3 (es) | Piridiniminil-1,2-benzisoxazol y -benzisotiazol como antipsicoticos. | |
IL111804A0 (en) | Pharmaceutical compositions comprising dimeticone for the treatment of constipation |